Cephalon Hit With FCA Suit Over Off-Label Marketing
By Helen Christophi ( March 18, 2013, 8:14 PM EDT) -- Cephalon Inc. was hit with a whistleblower suit in New York federal court Friday claiming the drugmaker submitted hundreds of thousands of false claims to federal and state health care programs by promoting its leukemia and pain medications for unapproved off-label uses....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.